Clin Case Rep Int | Volume 5, Issue 1 | Case Report | Open Access

Metabolic Acidosis due to Ketoacidosis in an Euglycemic Diabetic Patient with COVID-19 Infection: A Case Report

Tulin Akagun1*, Elvan Tekir Yilmaz2 , Tuna Albayrak2 and Hayriye Bektas Aksoy3

1 Department of Internal Medicine, Division of Nephrology, Giresun University, Turkey 2 Department of Anesthesiology, Giresun University, Turkey 3 Department of Pulmonary Disease, Giresun University, Turkey

*Correspondance to: Tulin Akagun 

Fulltext PDF

Abstract

Diabetes is the one of the most frequently detected comorbidities in patients infected with COVID-19. A few case reports also were published that COVID-19 may cause acute hyperglycemic crises (DKA/ HHS) in patients with inadequately controlled diabetes, as well as newly diagnosed diabetes. We report a metabolic acidosis due to ketoacidosis in an euglycemic diabetic patient with COVID-19 pneumonia. COVID-19 infection may cause fat breakdown and induce ketosis, ketoacidosis may develop at the end of the process.

Keywords:

COVID-19; Diabetes mellitus; Ketoacidosis

Citation:

Akagun T, Yilmaz ET, Albayrak T, Aksoy HB. Metabolic Acidosis due to Ketoacidosis in an Euglycemic Diabetic Patient with COVID-19 Infection: A Case Report. Clin Case Rep Int. 2021;5:1223..

Subscribe to Our Newsletter